Stock Price
0.68
Daily Change
-6.69%
Yearly
41.98%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Adma Biologics 1.29 -0.07 -5.15% -35.50%
Adamis Pharmaceuticals 0.68 -0.05 -6.69% 41.98%
Antares Pharma 3.15 -0.11 -3.37% -5.69%
Brainstorm Cell Therapeutics 3.33 -0.15 -4.31% -42.29%
Cara Therapeutics 12.31 -0.58 -4.50% -18.37%
Cerulean Pharma 1.78 0.09 5.33% 18.67%
GlaxoSmithKline 1,534.60 0.60 0.04% 10.72%
Glaxosmithkline 41.25 -0.22 -0.53% 10.00%
Merck & Co 73.34 -0.55 -0.74% -10.50%
Pfizer 54.27 1.23 2.32% 34.53%
RedHill Biopharma 2.55 -0.19 -6.93% -71.09%

Indexes Price Day Year
NASDAQ 15085 -295.85 -1.92% 21.03%

Adamis Pharmaceuticals
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company. It is focused on developing and commercializing products in therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its product includes, SYMJEP (epinephrine) Injection 0.3 miligram for treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more, and SYMJEPI (epinephrine) Injection 0.15 miligram for the treatment of anaphylaxis for patients weighing 33-65 pounds. Its other product candidates includes ZIMHI, a high dose 5 miligram naloxone injection, based on the approved Symject injection device for the treatment of opioid overdose, and APC-400 (tempol) for the treatment of respiratory diseases including asthma, respiratory syncytial virus, influenza and COVID-19, APC-1000 a hydrofluoroalkane (HFA) inhalable oral steroid for the treatment of asthma and COPD APC-4000 Fluticasone, a dry powder inhalation for the treatment of asthma.